🔎 Trials Near Me

Home › Hodgkin Lymphoma

Hodgkin Lymphoma clinical trials recruiting in the U.S.

62 studies for Hodgkin Lymphoma are recruiting participants at sites across the United States.

Hodgkin lymphoma is a type of lymphoma, cancer of the lymph system. It is serious but can usually be cured if found and treated early. Learn more.

Cities with the most studies

By state

Recently updated studies

Tissue Collection for Studies of Lymph Cancer

RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT01676805

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT03418038

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Sep 28, 2026 · NCT02682667

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT03618550

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05615636

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

RecruitingPhase 1
Ages 18 to 100 · All sexes · Updated Sep 15, 2026 · NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Sep 14, 2026 · NCT06137144

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT05272384

Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06421987

Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

RecruitingPhase 2
Ages 2 to 21 · All sexes · Updated Aug 31, 2026 · NCT07551583

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

Recruiting
All ages · All sexes · Updated Aug 21, 2026 · NCT07514819

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07021989

CD45BE-HSPC + CART-45 Cells

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT07451054

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT06090864

Personalized NK Cell Therapy in CBT

RecruitingPhase 2
Ages 15 to 80 · All sexes · Updated Jul 30, 2026 · NCT02727803

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT06150664

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Jul 20, 2026 · NCT06176690

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT06580002

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

RecruitingPhase 3
Ages 16 to 69 · All sexes · Updated Jul 8, 2026 · NCT04685616

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.